Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Transcriptome patterns and their regulation by alternative splicing in Parkinson’s disease.
Movement Disorders
P12 - Poster Session 12 (5:30 PM-6:30 PM)
5-006

Consequent to the loss of dopaminergic neurons in the substantia nigra in PD, the dopamine-dependent striatum undergoes molecular changes, resulting in motor  and non-motor symptoms. We sought to understand the molecular mechanisms involved in disease manifestation by investigating transcriptome changes in the PD striatum.

To investigate messenger RNA expression patterns and their regulation by alternative splicing in the striatum in Parkinson’s disease(PD) and Parkinson’s disease dementia(PDD).

We performed RNA-sequencing on post-mortem striatum (caudate and putamen) collected from healthy controls (n=40) and PD (n=35). We additionally compared RNA expression between PDD (n=16) and PD without dementia(n=11). Analysis was performed using Limma (differential gene expression),  Gene set enrichment analysis (pathway enrichment), and Multivariate Analysis of Transcript Splicing(alternative splicing). Significant change in  expression of genes was defined with the log2 fold change ≥ 0.5 and q-value < 0.05. Significantly spliced events were defined as difference in absolute percent spliced in (PSI) of >10% and q-value <0.05.

Differential gene expression analysis revealed 2405 and 2032 up and downregulated genes respectively in the PD relative to control caudate, and  3108 and 2486 genes up and downregulated genes  in PD putamen compared to controls.   Pathways regulating synaptic signaling and plasticity, mitochondrial protein complex, autophagy and microRNA activity were altered in PD. Unfolded protein response, circadian rhythm, protein localization to endoplasmic reticulum and histone acetylation pathways were altered in the caudate in PDD.  1362  and 1934 alternatively spliced messenger RNA(mRNA)s were discovered in caudate and putamen respectively, encoding proteins involved in dendrite morphogenesis, neurogenesis and splicing, with some gene transcripts exclusively spliced in PD. We identified predicted RNA binding proteins regulating these splice events and their functional consequences on proteins in PD.

These observations define the striatal transcriptomic landscape in PD and PDD and provide evidence that dysregulation of mRNA splicing is a key feature of PD.

Authors/Disclosures
Krithi Irmady, MD, MBBS (Rockefeller University)
PRESENTER
An immediate family member of Dr. Irmady has received personal compensation in the range of $0-$499 for serving as a Consultant for Adivo Associates LLC. An immediate family member of Dr. Irmady has stock in Doximity. The institution of Dr. Irmady has received research support from William N and Bernice E Bumpus Foundation. The institution of Dr. Irmady has received research support from American Academy of Neurology. An immediate family member of Dr. Irmady has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Cancer Prevention and Research Institute Texas(CPRIT). Dr. Irmady has received personal compensation in the range of $0-$499 for serving as a Reviewer with Luxembourg National Research fund . An immediate family member of Dr. Irmady has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Memorial Sloan Kettering Cancer Center.
No disclosure on file
No disclosure on file
No disclosure on file
Serge Przedborski, MD, PhD (Columbia University) Dr. Przedborski has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for eLife. The institution of Dr. Przedborski has received research support from NIH. The institution of Dr. Przedborski has received research support from DoD. The institution of Dr. Przedborski has received research support from Ludwig Foudantion. The institution of Dr. Przedborski has received research support from CZI.
No disclosure on file
Robert B. Darnell, MD, PhD (The Rockefeller University) Dr. Darnell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atreca, Inc.. Dr. Darnell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MITRE. Dr. Darnell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for OPNA.